et al. Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J. Clin. Oncol. 32, 504–512 (2014). 36. Mirkin, K. A., Greenleaf, E. K., Hollenbeak, C. S.